Journal Articles
In This Section
-
QJ 54.1 - Mending the Fence: Commercial Success & the Blocking Patent Defense in Pharmaceutical Litigation
John Jarosz, Andrea Hugill, Anna Gumen, and Michael Chapman
-
QJ 54.1 - Secret Methods, Public Sales: Reimagining the On-Sale Bar for Process Patents
Sameer Agrawal
-
QJ 54.1 - The Limits of Territoriality: Addressing Unauthorized Use of Foreign Famous Marks in the United States
Layla Huang
-
QJ 54.1 - Hidden in Plain Sight: Moral Rights, Cultural Stewardship, & “Destruction” After Kerson
Hannah Kressel-Levinson
-
QJ Volume 53 Article and Author Index
-
QJ 53.4 - Just a Generative AI User, Standing in Front of a Copyright Troll, Asking
it to Love Her: Generative AI, Copyright Trolls, and the Statutory Damages
Regime
Louise Strange
-
QJ 53.4 - Domestic Industry: Why the Analysis Should Change with the Times
Hank Stein
-
QJ 53.4 - Compounded Drugs: An Uprise of Trademark Infringement Lawsuits
Calling for More FDA Regulation
Vanessa Sabrina Bittar
-
QJ 53.4 - DMC-AI: An AntIvenom
Wade Witcher
-
AM25 Photos
-
“Open for Business”: USPTO Director John Squires Gives His First Public Remarks
-
Insights from the Special Session for Law Students
-
Live from the Annual Meeting: Posita Podcast with AIPLA President Sal Anastasi
-
Innovation Without Borders: Insights from the EUIPO
-
Innovation, Predictability, and the Future of IP Law: Remarks from the Hill
-
President’s Message – Sal Anastasi – Annual Meeting 2025
-
QJ 53.3 - The Dewberry Dilemma: How the Supreme Court Has Created a Freeway for Infringement Under the Lanham Act
Louis T. Juliano, Jr.
-
QJ 53.3 - Marked by Faith: A Justification for Religious Fair Use in Trademark Infringement Disputes
Summer Basham Todd
-
QJ 53.3 - Small Claims, Big Problems: A Critical Look at the Copyright “Small Claims Court”
K.C. Webb
-
QJ 53.2 - AlphaFold 3, AI, Antibody Patents, The Future of Broad Pharmaceutical Patent Claims, and Drug Development
Brendan Bargmann and Robert A. Bohrer